Trials / Conditions / Ebola Virus Infection
Ebola Virus Infection
4 registered clinical trials studyying Ebola Virus Infection.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Putative Investigational Therapeutics in the Treatment of Patients With Known Ebola Infection NCT02363322 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 / Phase 2 |
| Completed | A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BCX4430 NCT02319772 | BioCryst Pharmaceuticals | Phase 1 |
| Terminated | Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study for Intravenous (IV) TKM-100802 NCT02041715 | Arbutus Biopharma Corporation | Phase 1 |
| Terminated | Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study of Intravenous (IV) TKM-100201 Infusion NCT01518881 | Arbutus Biopharma Corporation | Phase 1 |